Observed arrival · 2026-11-14
Rhizome’s cited regulatory answers
An AI regulatory-intelligence tool for life-sciences teams, offering answers drawn from FDA, EMA, and other health-authority sources.
○Open
⊠Login
$Paid
†Ads
✦Pretty
●Pro
◎Niche
◉Human
⚑Risk
ƒJS
- For
- Life-sciences regulatory teams and consultants
- Worth noticing
- Its sample oncology-trial briefing distinguishes shared protocol design from US IND and EU CTIS/CTA filing procedures.
Field notes
The embedded example separates scientific protocol design shared across regions from procedural differences, including IND filing in the US and CTA filing through CTIS in the EU. The homepage reports coverage across 17 countries and 123 million indexed pages, and says more than 100 teams have used the service; these figures are presented by the site.
Observed signals
Read the marks
Editorial observations of this landing page, not a rating.
○OpenPublic substance visible
⊠LoginAccess appeared gated
$PaidCommerce or pricing visible
✦PrettyNotable craft visible
●ProPolished or operationally mature
◎NicheUnusually specific use
ƒJavaScriptBrowser-side code central
One card from the complete issue